{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T16:30:18Z","timestamp":1788453018426,"version":"build-2803163510"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T00:00:00Z","timestamp":1752019200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["1DP2DA053720"],"award-info":[{"award-number":["1DP2DA053720"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005564","name":"Gilead Sciences Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jsatjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Use and Addiction Treatment"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.josat.2025.209755","type":"journal-article","created":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T02:08:22Z","timestamp":1751854102000},"page":"209755","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Accessibility of methadone treatment via public transit for syringe services program participants in Miami-Dade County, Florida"],"prefix":"10.1016","volume":"176","author":[{"given":"Marina","family":"Plesons","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eileen","family":"Malecki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrina","family":"Ciraldo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Ashbes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Edward","family":"Suarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hansel E.","family":"Tookes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyler S.","family":"Bartholomew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.josat.2025.209755_bb0005","first-page":"1","article-title":"Trends in the use of methadone, buprenorphine, and extended-release naltrexone at substance abuse treatment facilities: 2003-2015 (update)","author":"Alderks","year":"2013","journal-title":"In the CBHSQ report"},{"issue":"3","key":"10.1016\/j.josat.2025.209755_bb0010","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1353\/hpu.2022.0104","article-title":"Drive times to methadone treatment among Medicaid patients","volume":"33","author":"Allen","year":"2022","journal-title":"Journal of Health Care for the Poor and Underserved"},{"key":"10.1016\/j.josat.2025.209755_bb0015","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.drugalcdep.2018.08.024","article-title":"Three-year retention in methadone opioid agonist treatment: A survival analysis of clients by dose, area deprivation, and availability of alcohol and cannabis outlets","volume":"193","author":"Amiri","year":"2018","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1016\/j.josat.2025.209755_bb0020","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1080\/00952990.2019.1620261","article-title":"Spatial access to opioid treatment program and alcohol and cannabis outlets: Analysis of missed doses of methadone during the first, second, and third 90 days of treatment","volume":"46","author":"Amiri","year":"2020","journal-title":"The American Journal of Drug and Alcohol Abuse"},{"issue":"2","key":"10.1016\/j.josat.2025.209755_bb0025","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jval.2020.08.2098","article-title":"Disparities in access to opioid treatment programs and office-based buprenorphine treatment across the rural-urban and area deprivation continua: A US Nationwide small area analysis","volume":"24","author":"Amiri","year":"2021","journal-title":"Value in Health"},{"key":"10.1016\/j.josat.2025.209755_bb0030","article-title":"Disparities in access to opioid treatment programs and buprenorphine providers by race and ethnicity in the contiguous U.S","volume":"156","author":"Amiri","year":"2024","journal-title":"J Subst Use Addict Treat"},{"issue":"6","key":"10.1016\/j.josat.2025.209755_bb0035","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1080\/00952990.2021.1979991","article-title":"The impact of relaxation of methadone take-home protocols on treatment outcomes in the COVID-19 era","volume":"47","author":"Amram","year":"2021","journal-title":"The American Journal of Drug and Alcohol Abuse"},{"key":"10.1016\/j.josat.2025.209755_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2023.109801","article-title":"Availability of timely methadone treatment in the United States and Canada during COVID-19: A census tract-level analysis","volume":"245","author":"Amram","year":"2023","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1016\/j.josat.2025.209755_bb0045","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s12954-023-00861-3","article-title":"Availability of telehealth-based services at syringe services programs under the COVID-19 public health emergency","volume":"20","author":"Bartholomew","year":"2023","journal-title":"Harm Reduction Journal"},{"key":"10.1016\/j.josat.2025.209755_bb0050","article-title":"Drug overdose mortality by state","author":"Centers for Disease Control and Prevention","year":"2022","journal-title":"Centers for Disease Control and Prevention"},{"key":"10.1016\/j.josat.2025.209755_bb0055","article-title":"Provisional Drug Overdose Death Counts","author":"Centers for Disease Control and Prevention (CDC)","year":"2025","journal-title":"Centers for Disease Control and Prevention"},{"issue":"25","key":"10.1016\/j.josat.2025.209755_bb0060","doi-asserted-by":"crossref","first-page":"567","DOI":"10.15585\/mmwr.mm7325a1","article-title":"Treatment for opioid use disorder: Population estimates - United States, 2022","volume":"73","author":"Dowell","year":"2024","journal-title":"MMWR. Morbidity and Mortality Weekly Report"},{"key":"10.1016\/j.josat.2025.209755_bb0065","series-title":"Whiteout: How racial capitalism changed the color of opioids in America","author":"Hansen","year":"2023"},{"issue":"3","key":"10.1016\/j.josat.2025.209755_bb0070","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s11414-013-9341-3","article-title":"Variation in use of buprenorphine and methadone treatment by racial, ethnic, and income characteristics of residential social areas in new York City","volume":"40","author":"Hansen","year":"2013","journal-title":"The Journal of Behavioral Health Services & Research"},{"issue":"5","key":"10.1016\/j.josat.2025.209755_bb0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0250324","article-title":"Opioid treatment deserts: Concept development and application in a US Midwestern urban county","volume":"16","author":"Hyder","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.josat.2025.209755_bb0080","series-title":"Federal regulation of methadone treatment","author":"Institute of Medicine","year":"1995"},{"issue":"1","key":"10.1016\/j.josat.2025.209755_bb0085","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13722-023-00394-x","article-title":"Three decades of research in substance use disorder treatment for syringe services program participants: A scoping review of the literature","volume":"18","author":"Jakubowski","year":"2023","journal-title":"Addiction Science & Clinical Practice"},{"issue":"9","key":"10.1016\/j.josat.2025.209755_bb0090","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1001\/jamapsychiatry.2022.1776","article-title":"Methadone-involved overdose deaths in the US before and after Federal Policy Changes Expanding Take-Home Methadone Doses from Opioid Treatment Programs","volume":"79","author":"Jones","year":"2022","journal-title":"JAMA Psychiatry"},{"issue":"13","key":"10.1016\/j.josat.2025.209755_bb0095","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1001\/jama.2019.12562","article-title":"Drive times to opioid treatment programs in urban and rural counties in 5 US states","volume":"322","author":"Joudrey","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.josat.2025.209755_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.jth.2022.101531","article-title":"Time-varying spatial accessibility of primary healthcare services based on spatiotemporal variations in demand, supply, and traffic conditions: A case study of Seoul, South Korea","volume":"27","author":"Kim","year":"2022","journal-title":"Journal of Transport & Health"},{"issue":"11","key":"10.1016\/j.josat.2025.209755_bb0105","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1001\/jamapsychiatry.2020.1624","article-title":"Comparison of driving times to opioid treatment programs and pharmacies in the US","volume":"77","author":"Kleinman","year":"2020","journal-title":"JAMA Psychiatry"},{"issue":"9","key":"10.1016\/j.josat.2025.209755_bb0110","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1001\/jamapsychiatry.2019.0876","article-title":"Buprenorphine treatment divide by race\/ethnicity and payment","volume":"76","author":"Lagisetty","year":"2019","journal-title":"JAMA Psychiatry"},{"issue":"4","key":"10.1016\/j.josat.2025.209755_bb0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0123687","article-title":"Factors associated with methadone treatment duration: A cox regression analysis","volume":"10","author":"Lin","year":"2015","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.josat.2025.209755_bb0120","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002207.pub4","article-title":"Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence","author":"Mattick","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1016\/j.josat.2025.209755_bb0125","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.psc.2021.11.006","article-title":"Coronavirus disease 2019 and the impact on substance use disorder treatments","volume":"45","author":"Melamed","year":"2022","journal-title":"The Psychiatric Clinics of North America"},{"key":"10.1016\/j.josat.2025.209755_bb0130","series-title":"Medications for opioid use disorder save lives","author":"National Academies of Sciences Engineering and Medicine","year":"2019"},{"issue":"2","key":"10.1016\/j.josat.2025.209755_bb0135","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/00005650-198102000-00001","article-title":"The concept of access: Definition and relationship to consumer satisfaction","volume":"19","author":"Penchansky","year":"1981","journal-title":"Medical Care"},{"key":"10.1016\/j.josat.2025.209755_bb0140","doi-asserted-by":"crossref","DOI":"10.32866\/001c.21262","article-title":"R5r: Rapid realistic routing on multimodal transport networks with R5 in R","author":"Pereira","year":"2021","journal-title":"Transport Findings"},{"issue":"2","key":"10.1016\/j.josat.2025.209755_bb0145","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1080\/01441647.2016.1257660","article-title":"Distributive justice and equity in transportation","volume":"37","author":"Pereira","year":"2017","journal-title":"Transport Reviews"},{"key":"10.1016\/j.josat.2025.209755_bb0150","article-title":"Socioeconomics of urban travel: Evidence from the 2001 NHTS","volume":"52","author":"Pucher","year":"2003","journal-title":"Transportation Quarterly"},{"key":"10.1016\/j.josat.2025.209755_bb0155","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/948789","article-title":"Distance traveled and cross-state commuting to opioid treatment programs in the United States","volume":"2011","author":"Rosenblum","year":"2011","journal-title":"Journal of Environmental and Public Health"},{"issue":"9","key":"10.1016\/j.josat.2025.209755_bb0160","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1001\/jamapsychiatry.2021.0976","article-title":"Association of Opioid Agonist Treatment with All-Cause Mortality and Specific Causes of death among people with opioid dependence: A systematic review and Meta-analysis","volume":"78","author":"Santo","year":"2021","journal-title":"JAMA Psychiatry"},{"issue":"4","key":"10.1016\/j.josat.2025.209755_bb0165","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/ADM.0000000000000952","article-title":"A Plea from people who use drugs to clinicians: New ways to initiate buprenorphine are urgently needed in the fentanyl era","volume":"16","author":"Sue","year":"2022","journal-title":"Journal of Addiction Medicine"},{"issue":"1","key":"10.1016\/j.josat.2025.209755_bb0170","doi-asserted-by":"crossref","DOI":"10.1186\/s12544-023-00596-z","article-title":"Definitions matter: Investigating indicators for transport poverty using different measurement tools","volume":"15","author":"Verhorst","year":"2023","journal-title":"European Transport Research Review"},{"key":"10.1016\/j.josat.2025.209755_bb0175","article-title":"Barriers to retention in medications for opioid use disorder treatment in real-world practice","volume":"160","author":"Villamil","year":"2024","journal-title":"J Subst Use Addict Treat"},{"issue":"1","key":"10.1016\/j.josat.2025.209755_bb0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/00952990.2018.1546862","article-title":"Development of a Cascade of care for responding to the opioid epidemic","volume":"45","author":"Williams","year":"2019","journal-title":"The American Journal of Drug and Alcohol Abuse"},{"key":"10.1016\/j.josat.2025.209755_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2023.104032","article-title":"Public transport access to drug treatment before and during COVID-19: Implications for the opioid epidemic","volume":"116","author":"Y\u00fccel","year":"2023","journal-title":"The International Journal on Drug Policy"},{"key":"10.1016\/j.josat.2025.209755_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.jth.2022.101334","article-title":"Exploring the temporal variations in accessibility to health services for older adults: A case study in greater London","volume":"24","author":"Zhang","year":"2022","journal-title":"Journal of Transport & Health"}],"container-title":["Journal of Substance Use and Addiction Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875925001341?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875925001341?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T20:26:50Z","timestamp":1754425610000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949875925001341"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":38,"alternative-id":["S2949875925001341"],"URL":"https:\/\/doi.org\/10.1016\/j.josat.2025.209755","relation":{},"ISSN":["2949-8759"],"issn-type":[{"value":"2949-8759","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Accessibility of methadone treatment via public transit for syringe services program participants in Miami-Dade County, Florida","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Use and Addiction Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.josat.2025.209755","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"209755"}}